| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CD40 ligand | 0.414 | 0.846 | 0.72 |
|
disease | 0.100 | None | 0.980 | 3 | 0 | 1975 | 2019 | ||||||||
|
CD79a molecule | 0.536 | 0.731 | 0.69 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 1975 | 2006 | ||||||||
|
CD5 molecule | 0.682 | 0.308 | 2.3E-10 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1986 | 2008 | ||||||||
|
T cell receptor gamma locus | 0.631 | 0.538 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 1986 | 2002 | |||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.500 | None | 0.974 | 3 | 0 | 1987 | 2020 | ||||||||
|
T cell leukemia/lymphoma 1A | 0.558 | 0.500 | 5.7E-10 |
|
disease | 0.100 | None | 0.988 | 3 | 0 | 1988 | 2020 | ||||||||
|
CD40 molecule | 0.396 | 0.846 | 0.85 |
|
disease | 0.100 | None | 0.963 | 2 | 0 | 1990 | 2018 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.100 | None | 0.951 | 2 | 0 | 1990 | 2019 | ||||||||
|
CD38 molecule | 0.407 | 0.885 | 2.3E-06 |
|
disease | 0.100 | None | 0.964 | 11 | 0 | 1991 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.800 | None | 0.977 | 7 | 0 | 1991 | 2020 | ||||||||
|
Fc fragment of IgE receptor II | 0.560 | 0.654 | 7.6E-12 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 1991 | 2019 | ||||||||
|
CD1c molecule | 0.633 | 0.692 | 1.6E-08 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 1991 | 2002 | ||||||||
|
membrane metalloendopeptidase | 0.407 | 0.808 | 1.5E-18 |
|
disease | 0.080 | None | 0.875 | 1 | 0 | 1991 | 2013 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.180 | None | 1.000 | 2 | 0 | 1993 | 2017 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1994 | 2017 | ||||||||
|
CD2 molecule | 0.641 | 0.577 | 0.47 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 1994 | 2008 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0.955 | 1 | 0 | 1994 | 2019 | ||||||||
|
marker of proliferation Ki-67 | 0.431 | 0.808 | 1.3E-28 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 1995 | 2016 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
disease | 0.100 | None | 0.920 | 2 | 0 | 1996 | 2019 | ||||||||
|
POU class 2 homeobox associating factor 1 | 0.608 | 0.615 | 0.57 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 1996 | 2005 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
disease | 0.070 | None | 1.000 | 2 | 0 | 1997 | 2014 | ||||||||
|
syndecan 1 | 0.445 | 0.769 | 8.4E-03 |
|
disease | 0.040 | None | 0.750 | 1 | 0 | 1997 | 2010 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.700 | None | 0.966 | 3 | 0 | 1998 | 2019 | ||||||||
|
MCL1 apoptosis regulator, BCL2 family member | 0.430 | 0.808 | 0.96 |
|
disease | 0.100 | None | 1.000 | 2 | 0 | 1998 | 2019 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 1998 | 2008 |